RA Capital Management

Latest statistics and disclosures from Ra Capital Management's latest quarterly 13F-HR filing:

Companies in the Ra Capital Management portfolio as of September 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Ascendis Pharma A S 18.28 5.58M 36.25
Wave Life Sciences Ltd shs 13.93 7.09M 21.75
Avexis 10.82 1.24M -5% 96.73
Biohaven Pharmaceutical Holding 6.74 2.00M -18% 37.38
Achillion Pharmaceuticals (ACHN) 5.53 13.63M 4.49
Ignyta 4.58 4.11M +2% 12.35
G1 Therapeutics 4.50 2.68M 18.55
Kala Pharmaceuticals Inc 4.36 2.11M NEW 22.84
Myovant Sciences 3.96 2.83M 15.47
AVEO Pharmaceuticals (AVEO) 3.74 11.33M +34% 3.65
BioCryst Pharmaceuticals (BCRX) 3.31 6.98M +35% 5.24
Zogenix 3.14 992268 -32% 35.05
Insmed Inc 2.04 722714 NEW 31.21
Kadmon Hldgs Inc Com stock 2.02 6.67M NEW 3.35
Acorda Therapeutics (ACOR) 1.92 900259 23.65
Immunomedics (IMMU) 1.87 1.48M NEW 13.98
Ra Pharmaceuticals 1.78 1.35M 14.60
Sangamo Biosciences (SGMO) 1.69 1.25M 15.00
Dicerna Pharmaceuticals 1.26 2.43M 5.75
Aquinox Pharmaceuticals Inc 0.91 710682 NEW 14.19
Clementia 0.89 585403 NEW 16.89
Tg Therapeutics 0.75 700000 11.85
Krystal Biotech Inc 0.63 700000 NEW 9.97
Vanda Pharmaceuticals (VNDA) 0.39 243971 NEW 17.90
Kalvista Pharmaceuticals 0.39 591070 7.36
Chiasma 0.32 1.40M NEW 2.55
Proteon Therapeutics 0.24 1.34M 2.00

Past 13F-HR SEC Filings by Ra Capital Management

View All Filings